Cite
Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial.
MLA
Livingston, Michael H., et al. “Intrapleural Dornase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA): A Study Protocol for a Randomized Controlled Trial.” Trials, vol. 18, June 2017, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13063-017-2026-0.
APA
Livingston, M. H., Mahant, S., Ratjen, F., Connolly, B. L., Thorpe, K., Mamdani, M., Maclusky, I., Laberge, S., Giglia, L., Walton, J. M., Yang, C. L., Roberts, A., Shawyer, A. C., Brindle, M., Parsons, S. J., Stoian, C. A., & Cohen, E. (2017). Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial. Trials, 18, 1–11. https://doi.org/10.1186/s13063-017-2026-0
Chicago
Livingston, Michael H., Sanjay Mahant, Felix Ratjen, Bairbre L. Connolly, Kevin Thorpe, Muhammad Mamdani, Ian Maclusky, et al. 2017. “Intrapleural Dornase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA): A Study Protocol for a Randomized Controlled Trial.” Trials 18 (June): 1–11. doi:10.1186/s13063-017-2026-0.